Proton therapy toxicity outcomes for localized prostate cancer: Long-term results at a comprehensive cancer center
Lists
Only you see this
Abstract
Proton therapy is associated with low rates of late grade ≥3 GU and GI toxicity. While rare, late grade 4 toxicities occurred in nine (0.3 %) patients. De-escalation to a total dose of 76 Gy(RBE) yields excellent clinical outcomes for patients with LR to U-IR disease with the potential for significant reductions in grade ≥3 late toxicity.
BibTeX
@inproceedings{sosa2024proton,
author = {Alan Sosa and Michael K. Rooney and Howard D. Thames and Jeremiah Sanders and David Swanson and Seungtaek Choi and Quynh‐Nhu Nguyen and Henry Mok and Deborah A. Kuban and X. Ron Zhu and Shalin Shah and Lauren L. Mayo and Karen E. Hoffman and Chad Tang and Sean E. McGuire and N Sahoo and Xiaodong Zhang and Andrew K. Lee and Thomas J. Pugh and Usama Mahmood and John W. Davis and Brian F. Chapin and Paul G. Corn and Reena Kudchadker and N. Ausat and Steven J. Frank},
title = {{Proton therapy toxicity outcomes for localized prostate cancer: Long-term results at a comprehensive cancer center}},
booktitle = {Clinical},
year = {2024},
doi = {10.1016/j.ctro.2024.100822},
}Loading related content...